ProPhase Labs, Inc. ($PRPH) Insider Transactions

Last updated: 2026-03-16 13:04 UTC | Total transactions: 27

In the last 12 months, insiders at ProPhase Labs, Inc. ($PRPH) filed 27 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.

ProPhase Labs, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).

Most Active Insiders

View all SEC Filings for ProPhase Labs, Inc. (PRPH).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Sept. 9, 2025 Karkus Ted William CEO & CHAIRMAN A warrants 500000 $0.00 500,000.0000 41,879,017 9999.99% 1.19%
Feb. 17, 2025 Hollenshead Stuart Chief Operating Officer A Option (right to buy) 500000 $0.00 500,000.0000 0 9999.99% 0.00%
Feb. 14, 2025 Hirsch Warren Director A Option (right to buy) 100000 $0.00 100,000.0000 0 9999.99% 0.00%
Feb. 14, 2025 GLECKEL LOUIS MD Director A Option (right to buy) 100000 $0.00 100,000.0000 0 9999.99% 0.00%
March 17, 2024 Karkus Ted William CEO & CHAIRMAN A Option (right to buy) 400000 $0.00 400,000.0000 0 9999.99% 0.00%
March 17, 2024 GLECKEL LOUIS MD Director A Option (right to buy) 70000 $0.00 70,000.0000 0 9999.99% 0.00%
Jan. 1, 2024 Latkin Jed Director A Option (right to buy) 500000 $0.00 500,000.0000 0 9999.99% 0.00%
March 17, 2024 Hirsch Warren Director A Option (right to buy) 70000 $0.00 70,000.0000 0 9999.99% 0.00%
March 17, 2024 Karkus Ted William CEO & CHAIRMAN A Option (right to buy) 400000 $0.00 400,000.0000 0 50.00% 0.00%
March 17, 2024 Barr Jason Michael Director A Option (right to buy) 70000 $0.00 70,000.0000 0 9999.99% 0.00%
June 16, 2023 GLECKEL LOUIS MD Director A Option (right to buy) 40000 $0.00 40,000.0000 0 9999.99% 0.00%
June 16, 2023 Barr Jason Michael Director A Option (right to buy) 40000 $0.00 40,000.0000 0 9999.99% 0.00%
June 16, 2023 Hirsch Warren Director A Option (right to buy) 40000 $0.00 40,000.0000 0 9999.99% 0.00%
June 19, 2023 GLECKEL LOUIS MD Director A Option (right to buy) 40000 $0.00 40,000.0000 0 9999.99% 0.00%
June 19, 2023 Hirsch Warren Director A Option (right to buy) 40000 $0.00 40,000.0000 0 9999.99% 0.00%
June 19, 2023 Barr Jason Michael Director A Option (right to buy) 40000 $0.00 40,000.0000 0 9999.99% 0.00%
April 4, 2023 Morse Robert A. Jr. CHIEF FINANCIAL OFFICER A Option (right to buy) 50000 $0.00 50,000.0000 0 9999.99% 0.00%
April 5, 2023 Karkus Ted William CEO & CHAIRMAN G Common Stock, par value $0.005 50000 $0.00 3,583,750.0000 0 1.38% 0.00%
April 5, 2023 Karkus Ted William CEO & CHAIRMAN G Common Stock, par value $0.005 50000 $0.00 3,583,750.0000 0 1.41% 0.00%
April 3, 2023 Karkus Ted William CEO & CHAIRMAN G Common Stock, par value $0.005 100000 $0.00 3,583,750.0000 0 2.71% 0.00%
April 3, 2023 Karkus Ted William CEO & CHAIRMAN A Option (right to buy) 500000 $0.00 500,000.0000 0 9999.99% 0.00%
Feb. 1, 2023 Karkus Ted William CEO & CHAIRMAN F Common Stock, par value $0.005 268337 $8.18 3,683,750.0000 0 6.79% 0.00%
Feb. 1, 2023 Karkus Ted William CEO & CHAIRMAN M Common Stock, par value $0.005 500000 $0.60 3,952,087.0000 0 14.48% 0.00%
Feb. 1, 2023 Karkus Ted William CEO & CHAIRMAN M Option (right to buy) 500000 $0.00 0.0000 0 100.00% 0.00%
Jan. 13, 2023 Karkus Ted William CEO & CHAIRMAN M Common Stock, par value $0.005 600000 $0.60 3,771,318.0000 0 18.92% 0.00%
Jan. 13, 2023 Karkus Ted William CEO & CHAIRMAN M Option (right to buy) 600000 $0.00 500,000.0000 0 54.55% 0.00%
Jan. 13, 2023 Karkus Ted William CEO & CHAIRMAN F Common Stock, par value $0.005 319231 $9.36 3,452,087.0000 0 8.46% 0.00%